Member Research and Reports

Member Research and Reports

Columbia: ICAP Supports Malaria Prevention in Sierra Leone and Ethiopia

Malaria is one of the most serious health challenges in Sierra Leone, where malaria-related illness and death rates are among the highest worldwide, especially among children under five years of age.

Protecting these vulnerable lives requires a multi-pronged approach, including intermittent preventive treatment in infants (IPTi), whether or not they are infected. In 2016, ICAP began partnering with Sierra Leone’s National Malaria Control Program (NMCP), with support from the U.S. Centers for Disease Control and Prevention (CDC) to make Sierra Leone the first country to roll out IPTi nationwide. After piloting the initiative in four counties, IPTi began a country-wide scale-up in 2018.

ICAP has been a strong partner with the Ministry of Health and Sanitation as it seeks to strengthen national human resources for health, improve infection prevention and control, and increase immunization coverage. ICAP supports NMCP’s goal of reducing malaria-related illness and death by 40 percent by 2020.

In Ethiopia, ICAP continues to improve malaria detection, diagnosis, and treatment. While an estimated 2.7 million cases of malaria occur every year, many people still do not get the help they need although insecticide-treated nets and other prevention methods have made an impact. Building on more than a decade of work, funded by the U.S. Agency for International Development (USAID) through the President’s Malaria Initiative (PMI), ICAP’s current malaria diagnosis and treatment activity began in 2018 and has been implemented in 680 health facilities.

Working with the Ministry of Health, ICAP assessed gaps in resources, equipped labs for improved diagnostic service, trained personnel and provided mentorship and support supervision. ICAP has now trained approximately 9,400 health care workers.